Perforin Activity Modulation by Cathepsin B
Corresponding Organization :
Other organizations : Inserm, Centre National de la Recherche Scientifique
Variable analysis
- Pretreatment of purified human liver cathepsin B (CatB) with or without 10 μM CA074 for 30 min at 37 °C
- Pretreatment of lytic granule lysates with or without melanoma cell vesicular fraction lysates for 2 h at 37 °C
- Pretreatment of melanoma cell vesicular fraction lysates with or without 10 μM CA074 for 30 min at 37 °C
- Cell permeabilization measured by FACS analysis in the presence of 25 μg ml^-1 PI
- 1 × 10^6 Jurkat cells
- 125 ng of purified human perforin
- 500 ng ml^-1 purified human liver cathepsin B (CatB)
- 2 h incubation at 37 °C
- Purified human perforin (Enzo Life) without any pretreatment
- Purified human liver cathepsin B (CatB) pretreated with 10 μM CA074 for 30 min at 37 °C
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!